Novotech News

31. Novotech Earns Renewed Certification As An Employer Of Choice For Gender Equality 7/31/2024

    Novotech, a global biotech specialist CRO, proudly announces its continued recognition as a Workplace Gender Equality Agency (WGEA) Employer of Choice for Gender Equality (EOCGE) in 2024. This marks another milestone in Novotech's ongoing commitment to fostering an inclusive and equitable workplace.

32. New Report Highlights Global Trends And Advances In Chronic Lymphocytic Leukemia Research And Treatment 7/12/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has today released a significant research report entitled Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trial Landscape.

33. Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally 7/5/2024

    Novotech, a global full-service clinical Contract Research Organization (CRO) specializing in partnering with biotech companies to expedite the development of cutting-edge therapeutics across all phases, has today published a leading industry report, Liver Cancer - Global Clinical Trial Landscape.

34. Novotech Report Analyses Epilepsy Research Trends Finding More than 4,000 Clinical Trials Conducted Globally 7/2/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report entitled Epilepsy - Global Clinical Trial Landscape.

35. Novotech Publishes Report On Research Into Endometrial Cancer, A Leading Cause Of Gynecology Malignancy Mortality  6/28/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report - Endometrial cancer - Global Clinical Trial Landscape.

36. Novotech Appoints Dr. Ian Braithwaite As Vice President, Global Project Management To Lead World-Class Clinical Program Operations 6/28/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has appointed Dr. Ian Braithwaite as Vice President, Global Project Management.

37. ​​​Antibody-Drug Conjugates Shift The Cancer Treatment Landscape: Novotech Whitepaper Examines Latest Clinical Trial Data 6/28/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has today released a key research whitepaper entitled Antibody-drug conjugates - Global Clinical Trial Landscape.

38. Novotech Announces MOU With Experienced Psychedelics Research Center At The 4^th Annual Psychedelic Therapeutics And Drug Development Conference In Boston 6/24/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has signed an Memorandum of Understanding (MOU) with New Zealand Clinical Research (NZCR).

39. Novotech Launches Dedicated Early Phase Unit For Biotechs Leveraging The Australian And New Zealand Clinical Environment 6/4/2024

    Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced the launch of a dedicated early phase unit focussed on leveraging the unique advantage of Australian and New Zealand (ANZ) for early phase clinical development.

40. Novotech Signs Strategic MOU With Hong Kong-Shenzhen Innovation And Technology Park Limited (HSITPL) 5/31/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced it has signed a Memorandum of Understanding (MOU) with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL).